STAT3 and neoplasm: In the present study we report two main observations: First, we identified NFκB activation as a novel off target effect of control plasmid transcribed shRNAs; secondly, we demonstrate that effective STAT3 silencing induces NFκB activation that may compensate for the role of STAT3 in tumor cell survival.